[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100190123":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":18,"centralContacts":23,"locations":32,"responsibleParty":50,"collaborators":10,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":55,"sex":59,"minAge":60,"maxAge":10,"enrollmentInfo":61,"targetDuration":10,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"California Pacific Medical Center Research Institute","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Mucosal tumors of the colon",null,"Patients who received endoscopic treatment for noninvasive mucosal tumors of the colon.",{"label":13,"type":10,"description":14,"interventionNames":10},"Nonampullary tumors of the duodenum","Patients who received endoscopic treatment for noninvasive mucosal tumors of the duodenum.",{"label":16,"type":10,"description":17,"interventionNames":10},"Ampullary tumors","Patients who received endoscopic treatment for noninvasive ampullary tumors.",[19],{"name":20,"affiliation":21,"role":22},"Kenneth F Binmoeller, M.D.","California Pacific Medical Center","PRINCIPAL_INVESTIGATOR",[24,29],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Jona C Bernabe","CONTACT","415-600-1151","jona.bernabe@sutterhealth.org",{"name":30,"role":26,"phone":27,"phoneExt":10,"email":31},"Hayden Sampson","Hayden.sampson@sutterhealth.org",[33],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Interventional Endoscopy Services","RECRUITING","San Francisco","California","94115","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-122.41942,37.77493,{"lat":45,"lon":44},[48],{"name":25,"role":26,"phone":10,"phoneExt":10,"email":49},"CalitiJ@sutterhealth.org",{"type":22,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Kenneth Binmoeller","Interventional Endoscopy Services Program Director","100190123","clinical-outcomes-of-the-endoscopic-resection-of-premalignant-and-malignant-gastrointestinal-lesions-100190123",false,"NCT01750619","Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions","Inclusion Criteria:\n\n* Patients age \\>18 years that have been referred for endoscopic treatment of GI lesions.\n\nExclusion Criteria:\n\n* Patients for whom endoscopic treatment was not performed.","ALL","18 Years",{"count":62,"type":63},8000,"ESTIMATED","OBSERVATIONAL","To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.",[67,68],"Gastrointestinal Neoplasms","Benign Neoplasm of Intestinal Tract","2026-03-20",{"date":71,"type":72},"2026-03-23","ACTUAL",{"date":74,"type":10},"2011-07",{"date":76,"type":63},"2030-12",{"name":5,"class":6},1]